Literature DB >> 11268302

Anxiety/uncertainty reduction as a motivation for interest in prophylactic oophorectomy in women with a family history of ovarian cancer.

K E Hurley1, S M Miller, J W Costalas, D Gillespie, M B Daly.   

Abstract

Most women at familial risk for ovarian cancer must decide about prophylactic oophorectomy without conclusive genotypic information about their risk level. Some women with relatively low-risk profiles seek prophylactic oophorectomy or are recommended the procedure by their physicians, if they appear "cancerphobic." This study investigated the desire to reduce anxiety in relation to other factors associated with interest in prophylactic oophorectomy in a group of women with varying degrees of familial risk for ovarian cancer. Ninety-four women enrolled in an ongoing program for women with a family history of ovarian cancer received personalized risk counseling and were classified as having a sporadic, familial, or putative hereditary pedigree by a genetics counselor. Eligible enrollees were interviewed by telephone about current and future interest in prophylactic oophorectomy, perceived risk of ovarian cancer, severity of cancer anxiety, stress-related ideation, and reasons for and against surgery. Reduction of anxiety/uncertainty was the factor most strongly associated with current interest in prophylactic oophorectomy, independent of objective risk classification, perceived risk, severity of cancer anxiety, intrusive ideation, or other variables. Future interest in prophylactic oophorectomy was predicted by other perceived benefits of surgery. Current, but not future, interest in prophylactic oophorectomy appears motivated in part by seeking immediate relief from anxiety. Interest in prophylactic oophorectomy may fluctuate based on varying exposure to cues that trigger anxiety. Women seeking prophylactic oophorectomy, particularly those with lower-risk family pedigrees, should be offered options for anxiety management as part of informed consent for prophylactic oophorectomy.

Entities:  

Mesh:

Year:  2001        PMID: 11268302     DOI: 10.1089/152460901300039566

Source DB:  PubMed          Journal:  J Womens Health Gend Based Med        ISSN: 1524-6094


  12 in total

1.  The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome.

Authors:  Ramona Moldovan; Sianan Keating; Tara Clancy
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

2.  Predictors of risk-reducing surgery intentions following genetic counseling for hereditary breast and ovarian cancer.

Authors:  Mary Kathleen Ladd; Beth N Peshkin; Leigha Senter; Shari Baldinger; Claudine Isaacs; Hannah Segal; Samantha Philip; Chloe Phillips; Kate Shane; Aimee Martin; Veronique Weinstein; Robert Pilarski; Joanne Jeter; Kevin Sweet; Bonnie Hatten; Elisabeth J Wurtmann; Shanda Phippen; Della Bro; Marc D Schwartz
Journal:  Transl Behav Med       Date:  2020-05-20       Impact factor: 3.046

3.  Preserving the self: the process of decision making about hereditary breast cancer and ovarian cancer risk reduction.

Authors:  A Fuchsia Howard; Lynda G Balneaves; Joan L Bottorff; Patricia Rodney
Journal:  Qual Health Res       Date:  2010-10-27

4.  Catalysts to withdrawal from familial ovarian cancer screening for surgery and reactions to discontinued screening: a qualitative study.

Authors:  Kate J Lifford; Alison Clements; Lindsay Fraser; Deborah Lancastle; Kate Brain
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

5.  Decision making with uncertain information: learning from women in a high risk breast cancer clinic.

Authors:  Caren J Frost; Vickie Venne; Dianne Cunningham; Ruth Gerritsen-McKane
Journal:  J Genet Couns       Date:  2004-06       Impact factor: 2.537

6.  Predictors of cancer worry in unaffected women from high risk breast cancer families: risk perception is not the primary issue.

Authors:  Melanie Anne Price; Phyllis Noami Butow; Sing Kai Lo; Judy Wilson
Journal:  J Genet Couns       Date:  2007-09-09       Impact factor: 2.537

7.  Long-term outcomes of risk-reducing surgery in unaffected women at increased familial risk of breast and/or ovarian cancer.

Authors:  Louise Heiniger; Phyllis N Butow; Joseph Coll; Tracey Bullen; Judy Wilson; Brandi Baylock; Bettina Meiser; Melanie A Price
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

8.  Misperceptions of ovarian cancer risk in women at increased risk for hereditary ovarian cancer.

Authors:  Bettina Meiser; Melanie A Price; Phyllis N Butow; Belinda Rahman; Kathy Tucker; Benjamin Cheah; Adrian Bickerstaffe; John Hopper; Kelly-Anne Phillips
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

Review 9.  Women's decision making about risk-reducing strategies in the context of hereditary breast and ovarian cancer: a systematic review.

Authors:  A Fuchsia Howard; Lynda G Balneaves; Joan L Bottorff
Journal:  J Genet Couns       Date:  2009-10-03       Impact factor: 2.537

10.  Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy.

Authors:  A Fuchsia Howard; Joan L Bottorff; Lynda G Balneaves; Charmaine Kim-Sing
Journal:  BMC Womens Health       Date:  2010-08-05       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.